© Versita Sp. z o.o. C NMR spectral data. All the synthesized compounds were screened against six bacterial pathogens, namely B. subtilis, C. tetani, S. pneumoniae, S. typhi, V. cholerae, E. coli and for antifungal activity against two fungal pathogens, A. fumigatus and C. albicans using the broth microdilution MIC method. Some of the compounds were found to be equipotent or more potent than commercial drugs against most of employed strains, as evident from the screening data.
Introduction
The steadily increasing microbial resistance to existing first drugs is a serious problem in antimicrobial cure and necessitates continuing research into new classes of antimicrobials [1] . Moreover, the progression of drugresistant strains has contributed to the inefficiency of antimicrobial therapy. This has led to enormous interest in antibacterial research, and we strongly believe that there is an urgent call for development of new drugs with diverse and unique structures and with novel mechanisms of action from that of existing first line drugs. Consequently, this area of research is significant and attracts much attention of an increasing number of medicinal chemists.
Recently, we have been particularly interested in the synthesis of N-arylpyrazole and 4H-chromene incorporating structures for antimicrobial evaluation [2] on the premise that N-arylpyrazole is a chemically useful synthon bearing diverse biological activities like antimicrobial [3] [4] [5] , anti-inflammatory (COX-2 inhibitor and ulcerogenic activity) [4] , antitubercular [5] , antitumor [6, 7] , antiangiogenesis [7] , anti-parasitic [8] , antiviral [9] , analgesic and anxiolytic activity [10] . Moreover, the 4H-pyrano [3,2-c] chromene nucleus is a fertile source of biologically important molecules possessing a wide spectrum of pharmacological activities, such as antimicrobial [11], antiviral [12] , mutagenicity [13] , antiproliferative [14] , sex pheromone [15] , antitumor [16] , cancer therapy [17] and central nervous system activity [18] .
Despite their importance from pharmacological and synthetic point of views, comparatively few modified methods for the preparation of 4-aryl-4H-pyrano [3,2-c] chromene derivatives [19] have been reported using piperidine, morpholine, K 2 CO 3 , diammonium hydrogen phosphate, H 6 [P 2 W 18 O 62 ]•18H 2 O, tetrabutylammonium bromide or water using various aromatic/heterocyclic aldehydes, wherein not a single reference have been found where 3-methyl-5-aryloxy-1-aryl-1H-pyrazole-4-carbaldehyde is used. Thus, in view of the biological significance of 4H-chromene, a modification of the 4-position on 4H-pyrano [3,2-c] chromene by 3-methyl-5-phenoxy-1-phenyl-1H-pyrazole is undertaken to check whether it may bring significant changes in the bioactivities of 4H-chromene derivatives. As a part of our current studies in developing new antimicrobial agents via combination of two therapeutically active moieties Central European Journal of Chemistry * E-mail: patelranjanben@yahoo.com Department of Chemistry, Sardar Patel University, Gujarat, India [20], we have prepared and report herein pyrano [3,2-c] chromene IVa-x derivatives via MCR approach. The identity of all the products was confirmed using elemental analysis, FT-IR, 1 H NMR and 13 C NMR spectrometry. The compounds were subjected to an in vitro antimicrobial screening against a representative panel of eight human pathogens, of which three Gram-positive bacterial pathogens Streptococcus pneumoniae, Clostridium tetani, Bacillus subtilis, three Gram-negative bacterial pathogens Salmonella typhi, Vibrio cholerae, Escherichia coli and two fungal pathogens Aspergillus fumigatus and Candida albicans, using broth microdilution MIC (Minimum Inhibitory Concentration) method [21] .
Experimental Procedure

Chemistry
Solvents used were of analytical grade. Phenyl hydrazine was distilled before used; all other reagents were commercially available and used without further purification. All melting points were taken in open capillaries and are uncorrected. Thin-layer chromatography (TLC, on aluminium plates precoated with silica gel, 60F 254 , 0.25 mm thickness) (Merck, Darmstadt, Germany) was used for monitoring the progress of all reactions, purity and homogeneity of the synthesized compounds; eluent-hexane:ethyl acetale 6:4. UV radiation and/or iodine were used as the visualizing agents. Elemental analysis (% C, H, N) was carried out by a Perkin-Elmer 2400 series-II elemental analyzer (Perkin-Elmer, USA) and all compounds were within ±0.4% of calculation. The IR spectra were recorded in KBr on a Perkin-Elmer Spectrum GX FT-IR Spectrophotometer (Perkin-Elmer, USA), and only the characteristic peaks were reported in cm -1 . 1 H-NMR and 13 C-NMR spectra were recorded in DMSO-d 6 on a Bruker Avance 400F (MHz) spectrometer (Bruker Scientific Corporation Ltd., Switzerland) using solvent peak as internal standard at 400 MHz and 100 MHz respectively. Chemical shifts were reported in parts per million (ppm). Mass spectra were scanned on a Shimadzu LCMS 2010 spectrometer (Shimadzu, Tokyo, Japan).
2.2.
1-Aryl-5-chloro-3-methyl-1H-pyrazole-4-carbaldehydes were prepared, according to literature procedure [22] , by Vilsmeier-Haack reaction of 3-methyl-1-aryl-1H-pyrazol-5(4H)-one (Scheme 1).
2.3.
3-Methyl-5-aryloxy-1-aryl-1H-pyrazole-4-carbaldehydes Ia-l were prepared, according to literature procedure [23] , by nucleophilic reaction of 1-Aryl-5-chloro-3-methyl-1H-pyrazole-4-carbaldehyde and the respective phenol in presence of basic catalyst (K 2 CO 3 ) (Scheme 1).
2.4.
4-Hydroxy-6-(substituted)-2H-chromen-2-one was synthesized, according to literature procedure [24] by the solid phase reaction of malonic acid and phenol in phosphorous oxychloride in the presence of zinc chloride (Scheme 1).
2.5.
A mixture of the appropriate 1H-pyrazole-4-carbaldehyde Ia-l (30 mmol), malononitrile II (30 mmol) and 4-hydroxy coumarin IIIa-b (30 mmol) in ethanol (20 mL) containing a catalytic amount of piperidine was stirred and refluxed for 1-1.5 h. Upon completion of the reaction as determined by TLC (ethyl acetate:hexane::1:1), the reaction mixture was cooled to room temperature. The solid separated was filtered and washed with ethanol to obtain the pure compounds IVa-x. Physical, analytical and spectroscopic characterization data of the synthesized compounds Ia-l and IVa-x are given below: 108.92, 116.21, 122.81, 124.65, 128.01, 129.24, 130.25, 136.90, 150.83, 152.52, 108.77, 116.33, 123.02, 124.44, 127.97, 129.25, 130.63, 137.01, 150.78, 152.64, 108.90, 116.33, 122.67, 124.42, 128.03, 129.54, 130.33, 137.05, 150.73, 152.58, 157 108.88, 116.33, 122.87, 124.84, 128.09, 129.33, 130.26, 137.03, 151.03, 152.55, 108.87, 116.32, 122.45, 124.55, 128.23, 129.34, 130.67, 136.88, 150.87, 152.61, 108.99, 115.93, 122.81, 124.67, 128.08, 129.87, 131.03, 137.05, 150.64, 152.67, 108.66, 116.86, 122.67, 124.34, 128.22, 129.44, 130.65, 137.17, 151.05, 153.02, 157 108.97, 116.90, 123.05, 124.52, 128.14, 129.29, 130.41, 137.04, 150.57, 152.88, 108.88, 116.33, 119.22, 121.99, 123.89, 127.84, 129.42, 130.25, 137.03, 142.57, 150.81, 151.92, 13 C NMR (100 MHz, DMSO-d 6 ) δ C (ppm): 14.27, 20.29 (Ar-CH 3 ), 108.95, 116.55, 119.13, 122.87, 124.43, 128.11, 129.24, 130.37, 136.88, 142.12, 151.04, 152.02, 13 C NMR (100 MHz, DMSO-d 6 ) δ C (ppm): 14.12 (Ar-CH 3 ), 108.88, 116.33, 119.47, 122.67, 124.61, 128.22, 129.63, 130.48, 136.96, 142,27, 150.97, 153.01, 157 .07 (Ar-C), 183.67 (C=O); Anal. Calcd. for C 17 H 12 Cl 2 N 2 O 2 (347.20 gm/mole): C, 58.81; H, 3.48; N, 8.07%. Found: C, 59.07; H, 3.71; N, 7.93%. 108.72, 116.24, 118.97, 123.99, 124.69, 127.94, 129.31, 131.55, 137.23, 141.98, 150.74, 152.88, 103.08, 110.21, 112.48, 114.25, 116.86, 119.57, 120.94, 122.55, 124.40, 126.95, 129.31, 130.21, 132.18, 132.88, 137.86, 146.03, 148.39, 152.16, 153.43, 153.89, 158.48 13 C NMR (100 MHz, DMSO-d 6 ) δ C (ppm): 13.06, 20.23 (Ar-CH 3 ), 26.54 (C4), 56.11 (C-CN), 102.29, 110.48, 112.69, 113.69, 116.56, 119.97, 121.54, 122.70, 124.50, 127.05, 129.65, 130.11, 132.16, 132.78, 138.06, 145.83, 148.19, 152.26, 153.43, 153.80, 158.58 13 C NMR (100 MHz, DMSO-d 6 ) δ C (ppm): 13.05 (Ar-CH 3 ) 26.52 (C4), 55.90 (C-CN), 102.17, 110.34, 112.47, 113.86, 115.56, 119.77, 120.34, 122.38, 123.51, 126.15, 128.55, 131.01, 132.26, 132.88, 137.26, 144.85, 148.09, 152.14, 153.43, 154.21 103.48, 111.08, 112.19, 113.66, 115.86, 118.99, 121.44, 122.66, 124.59, 126.95, 128.61, 130.31, 132.16, 132.88, 138.02, 144.83, 147.49, 152.22, 153.44, 154.13, 103.59, 110.98, 111.96, 113.68, 116.55, 119.07, 120.94, 122.77, 124.55, 127.04, 129.15, 130.21, 131.76, 132.75, 138.16, 145.23, 148.49, 152.28, 153.43, 153.88, 158.59 102.99, 111.38, 112.45, 114.28, 115.76, 119.33, 121.83, 121.96, 123.51, 127.15, 129.32, 130.11, 132.23, 132.80, 138.34, 145.82, 148.48, 152.27, 153.15, 153.43, 102.89, 110.84, 112.44, 112.99, 116.26, 119.43, 120.57, 121.84, 124.34, 126.15, 129.03, 130.41, 132.17, 132.88, 138.36, 145.82, 147.29, 152.66, 153.44, 153.21, 110.12, 111.06, 113.33, 116.16, 119.72, 121.31, 121.98, 123.51, 127.21, 128.95, 130.18, 132.36, 132.88, 137.56, 144.33, 147.29, 152.36, 153.52, 154.35, 158.56 -CN) , 103.20, 111.02, 112.57, 115.81, 116.68, 119.70, 119.84, 121.16, 122.59, 124.80, 126.99, 127.53, 129.88, 131.46, 133.20, 134.05, 138.90, 145.44, 148.33, 151.20, 152.21, 154.57, (C-CN) , 102.49, 110.38, 112.07, 114.87, 117.08, 119.36, 119.85, 120.56, 121.99, 124.30, 126.03, 127.55, 129.17, 130.66, 133.28, 134.48, 138.70, 144.40, 146.92, 151.28, 152.77, 154.47, 158.51 (C-CN) , 102.19, 111.35, 112.57, 115.81, 116.68, 119.70, 119.84, 121.16, 122.59, 124.80, 126.99, 127.53, 129.88, 131.46, 133.20, 134.05, 138.90, 145.44, 148.96, 152.20, 153.57, 154.42, 158.61 103.66, 111.93, 112.14, 115.77, 117.05, 119.34, 119.96, 121.34, 122.41, 124.47, 125.92, 127.31, 129.07, 131.33, 132.89, 134.13, 138.16, 143.99, 147.06, 151.97, 153.49, 154.63, 158.37 102.23, 110.39, 112.47, 114.62, 114.77, 116.32, 119.99, 121.54, 122.27, 127.03, 129.66, 133.65, 133.87, 138.12, 146.09, 148.13, 149.68, 150.45, 153.39, 154.90, 158.63 (C-CN) , 102.39, 110.38, 112.03, 113.91, 117.21, 119.42, 121.19, 122.13, 122.83, 128.28, 130.19, 132.72, 133.42, 135.12, 136.54, 144.78, 147.79, 150.21, 154.03, 156.14, 102.31, 110.65, 112.13, 114.13, 116.32, 118.42, 121.38, 122.19, 122.87, 128.32, 130.02, 133.46, 133.74, 134.18, 136.44, 144.98, 146.11, 151.14, 153.33, 156.35, 158.29 (C-CN) , 103.03, 111.12, 112.78, 114.66, 117.41, 119.45, 121.37, 122.46, 122.92, 129.21, 130.18, 132.31, 133.43, 135.13, 136.88, 145.19, 147.83, 150.40, 153.03, 156.23, 158.55 (C-CN) , 102.62, 111.12, 112.62, 115.72, 117.04, 119.19, 119.64, 121.29, 122.32, 124.91, 126.85, 127.14, 129.67, 131.31, 133.48, 134.56, 138.78, 144.32, 148.13, 152.38, 153.28, 154.31, 110.92, 112.72, 115.37, 116.91, 118.94, 119.72, 121.47, 122.62, 124.77, 126.84, 127.42, 129.57, 131.14, 133.37, 134.18, 138.75, 145.32, 148.62, 152.11, 153.48, 154.31, 158.38 (C-CN) , 102.37, 111.42, 112.71, 114.92, 116.32, 119.62, 119.79, 120.97, 122.31, 124.62, 126.87, 127.62, 129.94, 131.21, 133.91, 134.17, 138.49, 144.33, 148.30, 152.35, 153.31, 154.52, 158.34 (C-CN) , 103.02, 111.91, 112.53, 115.42, 117.01, 119.82, 119.99, 121.50, 122.31, 124.72, 126.99, 127.53, 129.81, 131.53, 133.18, 134.17, 138.90, 145.32, 148.93, 152.23, 153.71, 154.35, 158.46 
Spectral data of compounds Ia-l and IVa-x
-M e t h y l -5 -( 4 -m e t h y l p h e n y l o x y ) -1 -( -chlorophenyl)-1H-pyrazole-4-carbaldehyde (Ij):
-M e t h y l -5 -( 4 -c h l o r o p h e n o x y ) -1 -( -
chlorophenyl
-M e t h y l -5 -( 4 -m e t h o x y p h e n o x y ) -1 -( -chlorophenyl)-1H-pyrazole-
-A m i n o -4 -( 5 -( 4 -c h l o r o p h e n o x y ) -3 -
-A m i n o -4 -( 5 -( 4 -m e t h o x y p h e n o x y ) -3 -methyl-1-phenyl-1H-pyrazol-4-yl)-5-oxo-
-A m i n o -4 -( 3 -m e t h y l -5 -p h e n o x y -1 -( 4 -m e t h y l p h e n y l ) -1 H -p y r a z o l -4 -y l ) -5 -o x o -
-A m i n o -4 -( 3 -m e t h y l -1 -p h e n y l -5 -( 4 -methylphenoxy)-1H-pyrazol-4-yl)-9-methyl-5-oxo-
2-Amino-4-(5-(4-methoxyphenoxy)-3-methyl-1-phenyl-1H-pyrazol-4-yl)-9-methyl-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carbonitrile (IVp):
-A m i n o -4 -( 3 -m e t h y l -5 -p h e n o x y -1 -( 4 -methylphenyl)-1H-pyrazol-4-yl)-9-methyl-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carbonitrile (IVq):
2-Amino-4-(3-methyl-1-(4-methylphenyl)-5-(4-methylphenoxy)-1H-pyrazol-4-yl)-9-methyl-5-oxo-
2-Amino-4-(5-(4-chlorophenoxy)-3-methyl-1-(4-methylphenyl)-1H-pyrazol-4-yl)-9-methyl-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carbonitrile (IVs):
Antimicrobial Activity
The in vitro antimicrobial activity of all the synthesized compounds and standard drugs were assessed against three representative of Gram-positive bacteria viz. Streptococcus pneumoniae (MTCC 1936) 8 CFUmL -1 (Colony Forming Unit per milliliter) by comparing the turbidity (turbidimetric method). Mueller Hinton Broth was used as nutrient medium to grow and dilute the compound suspension for the test bacteria. Sabouraud Dextrose Broth was used for fungal nutrition. Ampicillin, Chloramphenicol, Ciprofloxacin, Gentamicin and Norfloxacin were used as standard antibacterial drugs, whereas griseofulvin and nystatin were used as standard antifungal drugs. DMSO was used as a diluent / vehicle to obtain the desired concentration of synthesized compounds and standard drugs to test upon standard microbial strains. Serial dilutions were prepared in primary and secondary screenings. Each synthesized compound and standard drug was diluted obtaining 2000 μg mL -1 concentration, as a stock solution. In primary screening 1000, 500, and 250 μg mL -1 concentrations of the synthesized drugs were used. The active synthesized compounds found in this primary screening were further diluted to obtain 200, 100, 62.5 and 50 μg mL -1 concentrations for secondary screening to test in a second set of dilution against all microorganisms. The control tube containing no antibiotic is immediately subcultured [before inoculation] by spreading a loopful evenly over a quarter of plate of medium suitable for the growth of the test organism. The tubes are then put for incubation at 37°C for 24 h for bacteria and 48 h for fungi. The highest dilution (lowest concentration) preventing appearance of turbidity is considered as minimal inhibitory concentration (MIC, μg mL −1 ) i.e. the amount of growth from the control tube before incubation (which represents the original inoculum) is compared. A set of tubes containing only seeded broth and the solvent controls were maintained under identical conditions so as to make sure that the solvent had no influence on strain growth. The result of this is much affected by the size of the inoculum. The test mixture should contain 10 8 CFU mL -1 organisms. The protocols are summarized in Table 1 as the minimal inhibitory concentration (MIC, μg mL -1 ).
Results and Discussion
In continuation of our interest on synthesizing biologically potent antimicrobials [20] , we report herein a new series of dihydropyrano [3,2-c] chromene derivatives IVa-x via a one pot, three component, base-catalyzed cyclocondensation reaction of 3-methyl-5-aryloxy-1-ary-1H-lpyrazole-4-carbaldehyde Ia-l, malononitrile II and 4-hydroxycoumarin IIIa-b in ethanol. The required starting material, 1-aryl-5-chloro-3-methyl-1H-pyrazole-4-carbaldehydes were prepared by Vilsmeier-Haack reaction of 3-methyl-1-aryl-1H-pyrazol-5(4H)-one, which leads to chloroformylation to afford 1-aryl-5-chloro-3-methyl-1H-pyrazole-4-carbaldehyde according to literature procedure [22] . 1-Aryl-5-chloro-3-methyl-1H-pyrazole-4-carbaldehyde undergoes a nucleophilic substitution reaction with the respective phenol at refluxing temperature for 4 h in the presence of a base catalyst (K 2 CO 3 ) in DMF to yield the desired 3-methyl-5-aryloxy-1-aryl-1H-pyrazole-4-carbaldehyde Ia-l (Scheme 1) [23] . 4-Hydroxycoumarin (4-hydroxy-6-substituted-2H-chromen-2-one) was synthesized according to literature method by the solid phase reaction of malonic acid and phenol in phosphorous oxychloride in the presence of zinc chloride (Scheme 1) [24] .
To obtain the title pyrano[3,2-c]chromene derivatives of 1H-pyrazole, according to literature procedure, the reaction was carried out in aqueous media and under neutral conditions but failed to proceed even with prolonged refluxing. The reaction was also attempted under microwave irradiation but was not successful. The reaction proceeded in acetonitrile, methanol, benzene or DMF in the presence of morpholine or K 2 CO 3 , but required prolonged refluxing and resulted only in poor yield. Finally, refluxing the reaction mixture in ethanol for 1-1.5 h in the presence of piperidine as a basic catalyst gave moderate to good yield (62-80%) (Scheme 2). Hence, these conditions were considered as the most optimized conditions for the synthesis of the title derivatives.
A mechanism for the formation of the chromene derivatives IVa-x is outlined in Scheme 3. The reaction may proceed via an in situ initial formation of the hetarylidenenitrile, containing the electron-poor C=C double bond, from a Knoevenagel condensation. Finally, Michael addition of 3 to the initially formed unsaturated nitrile, i.e., nucleophilic attack of hydroxyl moiety to the cyano olefins afforded cyclized pyrano [3,2-c] 
The structures of all the newly synthesized compounds were established by 1 H-NMR, 13 C-NMR and FT-IR spectral data, and the molecular weight of some selected compounds were confirmed by mass spectrometry.
1 H-NMR (DMSO-d 6 ) spectrum of IVa-x exhibited a singlet peak around δ 4.40-4.50 stands for H4 of the pyran ring. Amine and aromatic protons of IVa-x resonate as multiplets at δ 6.30-7.60 ppm. A singlet around δ 1.75-2.40 ppm stands for methyl of the pyrazole ring.
13 C-NMR of IVa-x exhibited distinctive signals around δ 13.01-13.10 and δ 26.40-26.60 ppm stands for methyl of pyrazole ring and C4 of the pyran ring respectively. All the aromatic carbons of IVa-x showed signals around δ 102.15-158.70 ppm in the 13 C-NMR spectra. Moreover, distinctive signals around δ 55.50-56.60 and δ 160.01-160.15 ppm represent the C-CN and carbonyl carbon respectively. The IR spectrum of compound IVa-x exhibited characteristic absorption bands around 3450-3140 cm -1 and 2210-2180 cm -1 are inidicative of the (asym. & sym. str.) -NH 2 and -CN functional groups, respectively. The characteristic absorption band of carbonyl carbon is found around 1730-1680 cm -1 supports the formation of pyran derivative IVa-x. Further, the structure of selected compounds IVk and IVq were confirmed by its mass spectral studies. The mass spectra detected the expected molecular ion signals corresponding to respective molecular formula of synthesized compounds. Similarly, all these compounds were characterized on the basis of above spectral studies. All spectroscopic and physicochemical data have been given in experimental section. All the compounds were screened for their antibacterial and antifungal activity and results are shown in the form of MIC μg mL -1 .
Antibacterial screening
The examination of the data (Table 1 ) reveals that most of the compounds showed excellent antibacterial and antifungal activity when compared with standard drugs Ampicillin and Griseofulvin respectively. Against Gram-positive bacteria S. pneumoniae, compounds IVn (R 1 =H, R 2 =CH 3 , R 3 =CH 3 ) (MIC = 62.5 μg mL -1 ) was found to be more potent whereas, IVe (R 1 =CH 3 , R 2 =H, R 3 =H), IVf (R 1 =CH 3 , R 2 =CH 3 , R 3 =H), IVo (R 1 =H, R 2 =Cl, R 3 =CH 3 ) and IVu (R 1 =Cl, R 2 =H, R 3 =CH 3 ) (MIC = 100 μg mL -1 ) shows comparable activity, to Ampicillin (MIC = 100 μg mL -1 ). The compounds
and IVx (R 1 =Cl, R 2 =OCH 3 , R 3 =CH 3 ) (MIC < 250 μg mL -1 ) found to be more efficient whereas, IVa (R 1 =R 2 =R 3 =H), IVt (R 1 =CH 3 , R 2 =OCH 3 , R 3 =CH 3 ) and IVw (R 1 =Cl, R 2 =Cl, R 3 =CH 3 ) (MIC = 250 μg mL -1 ) were found equally potent to Ampicillin (MIC = 250 μg mL -1 ), towards C. tetani. The compounds IVb (R 1 =H, R 2 =CH 3 , R 3 =H), IVd (R 1 =H, R 2 =OCH 3 , R 3 =H), IVf (R 1 =CH 3 , R 2 =CH 3 , R 3 =H), IVh (R 1 =CH 3 , R 2 =OCH 3 , R 3 =H), IVk (R 1 =Cl, R 2 =Cl, R 3 =H), IVl (R 1 =Cl, R 2 =OCH 3 , R 3 =H), IVn (R 1 =H, R 2 = CH 3 , R 3 =CH 3 ), IVt (R 1 =CH 3 , R 2 =OCH 3 , R 3 =CH 3 ), IVu (R 1 =Cl, R 2 =H, R 3 =CH 3 ) and IVw (R 1 =Cl, R 2 =Cl, R 3 =CH 3 ) (MIC < 250 μg mL -1 ) shows better activity whereas, IVa (R 1 =R 2 =R 3 =H), IVe (R 1 =CH 3 , R 2 =H, R 3 =H), IVg (R 1 =CH 3 , R 2 =Cl, R 3 =H), IVi (R 1 =Cl, R 2 =H, R 3 =H), IVq (R 1 =CH 3 , R 2 =H, R 3 =CH 3 ), IVr (R 1 =CH 3 , R 2 = CH 3 , R 3 = CH 3 ), IVv (R 1 =Cl, R 2 =CH 3 , R 3 =CH 3 ) and IVx (R 1 =Cl, R 2 =OCH 3 , R 3 = CH 3 ) (MIC = 250 μg mL -1 ) found equally potent, to Ampicillin (MIC = 250 μg mL -1 ), against B. subtilis. Towards Gram-negative strain S. typhi, compounds IVd (R 1 =H, R 2 =OCH 3 , R 3 =H), IVf (R 1 =CH 3 , R 2 =CH 3 , R 3 =H), IVg (R 1 =CH 3 , R 2 =Cl, R 3 =H) and IVt (R 1 =CH 3 , R 2 =OCH 3 , R 3 =CH 3 ) (MIC = 100 μg mL -1 ) were equally active to Ampicillin (MIC = 100 μg mL -1 ). The Compounds 4c (R 1 =H, R 2 =Cl, R 3 =H), IVg (R 1 =CH 3 , R 2 =Cl, R 3 =H), IVk (R 1 =Cl, R 2 =Cl, R 3 =H) and IVr (R 1 = CH 3 , R 2 = CH 3 , R 3 = CH 3 ) (MIC = 100 μg mL -1 ) found equipotent to Ampicillin (MIC = 100 μg mL -1 ) against V. cholerae. The compound IVg (R 1 = CH 3 , R 2 =Cl, R 3 =H) and IVs (R 1 = CH 3 , R 2 =Cl, R 3 = CH 3 ) (MIC < 100 μg mL -1 ) shows better and IVd (R 1 =H, R 2 = OCH 3 , R 3 =H), IVf (R 1 = CH 3 , R 2 = CH 3 , R 3 =H), IVk (R 1 =Cl, R 2 =Cl, R 3 =H), IVl (R 1 =Cl, R 2 = OCH 3 , R 3 =H), IVn (R 1 =H, R 2 = CH 3 , R 3 = CH 3 ), IVq (R 1 = CH 3 , R 2 =H, R 3 = CH 3 ), IVu (R 1 =Cl, R 2 =H, R 3 = CH 3 ) and IVx (R 1 =Cl, R 2 = OCH 3 , R 3 = CH 3 ) (MIC = 100 μg mL -1 ) were found to exhibit comparable activity to Ampicillin (MIC = 100 μg mL -1 ) towards E. coli.
Antifungal screening
Against fungal pathogen C. albicans, compound IVa (R 1 =R 2 =R 3 =H), IVh (R 1 = CH 3 , R 2 = OCH 3 , R 3 =H), IVj (R 1 =Cl, R 2 = CH 3 , R 3 =H), IVn (R 1 =H, R 2 = CH 3 , R 3 = CH 3 ), IVs (R 1 = CH 3 , R 2 =Cl, R 3 = CH 3 ), IVt (R 1 = CH 3 , R 2 = OCH 3 , R 3 = CH 3 ), IVu (R 1 =Cl, R 2 =H, R 3 = CH 3 ) and IVv (R 1 =Cl, R 2 = CH 3 , R 3 = CH 3 ) (MIC < 500 μg mL -1 ) found better activity whereas, IVd (R 1 =H, R 2 = OCH 3 , R 3 =H), IVi (R 1 =Cl, R 2 =H, R 3 =H), IVl (R 1 =Cl, R 2 = OCH 3 , R 3 =H), IVm (R 1 =H, R 2 =H, R 3 = CH 3 ), IVr (R 1 = CH 3 , R 2 = CH 3 , R 3 = CH 3 ), IVw (R 1 =Cl, R 2 =Cl, R 3 = CH 3 ) and IVx (R 1 =Cl, R 2 = OCH 3 , R 3 = CH 3 ) (MIC = 500 μg mL -1 ) were found to be equipotent compared to Griseofulvin (MIC = 500 μg mL -1 ). The remaining compounds showed moderate to good activity to inhibit the growth of bacterial pathogens and are all less effective than standard drugs. From the antimicrobial study of the title derivatives, it is interesting to note that a minor alteration in the molecular configuration of the investigated compounds may have a pronounced effect on antimicrobial activity.
Conclusions
A new series of substituted pyrano [3,2-c] chromene IVa-x derivatives have been synthesized via MCR approach. This synthetic strategy allows the construction of relatively complicated nitrogen and oxygen containing fused heterocyclic systems, as well as the introduction of various (hetero)aromatic substitutents onto the 4-position of the chromene system. It can be concluded from antimicrobial screening ( Table 1) that compound Ivn, which bears two methyl groups, is the most efficient antimicrobial amongst all the synthesized derivatives. Antifungal activity of the compounds shows that most of the compounds wre found to be more potent against C. albicans compared to A. fumigatus. It is worth mentioning that minor changes in the molecular configuration of these compounds profoundly influences the activity.
